ILOTYCIN CRYST OP ONT 0.5% 52 .5 %
ERYTHROMYCIN : .5 % · DIN 00015970 · ELI LILLY CANADA INC
Health Canada status: CANCELLED POST MARKET
What is ILOTYCIN CRYST OP ONT 0.5% 52?
ILOTYCIN CRYST OP ONT 0.5% 52 .5 % contains ERYTHROMYCIN : .5 %. It is listed in the Health Canada Drug Product Database under DIN 00015970, held by ELI LILLY CANADA INC, supplied as OINTMENT for OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 26-Jul-2002. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00015970 |
|---|---|
| Brand name | ILOTYCIN CRYST OP ONT 0.5% 52 |
| Generic / active ingredient | ERYTHROMYCIN : .5 % |
| Manufacturer | ELI LILLY CANADA INC |
| Strength | .5 % |
| Dosage form | OINTMENT |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01AA17 ERYTHROMYCIN |
| AHFS class | 52:04.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 26-Jul-2002 |
| Original market date | 1954-12-31 00:00:00 |
Is ERYTHROMYCIN in shortage in Canada?
A Canadian shortage report is on file for this molecule: Anticipated — reported by PHARMA STULLN INC. (Tier 3 Drug Shortages About & Resources), last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code S01AA17 ERYTHROMYCIN. 3 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ERYTHROMYCIN | 5 MG | OINTMENT | PHARMA STULLN INC. | MARKETED | DIN 02141574 |
| ERYTHROMYCIN OPHTHALMIC OINTMENT USP | 5 MG | OINTMENT | STERI-MED PHARMA INC. | MARKETED | DIN 02326663 |
| PDP-ERYTHROMYCIN | 5 MG | OINTMENT | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 01912755 |
| ERYMYCIN OPHTHALMIC OINTMENT 5MG/G | 5 MG | OINTMENT | MM THERAPEUTICS INC | CANCELLED POST MARKET | DIN 02237041 |
| ERYTHROMYCIN OPHTHALMIC OINTMENT U.S.P. | 5 MG | OINTMENT | RIVEX OPHTHALMICS INC. | CANCELLED POST MARKET | DIN 02212935 |
| EURO-ERYTHROMYCIN OPHTHALMIC OINTMENT USP | 5 MG | OINTMENT | EURO-PHARM INTERNATIONAL CANADA INC | CANCELLED PRE MARKET | DIN 02460211 |
| ODAN-ERYTHROMYCIN | 5 MG | OINTMENT | ODAN LABORATORIES LTD | DORMANT | DIN 00641324 |
| PMS-ERYTHROMYCIN | 5 MG | OINTMENT | PHARMASCIENCE INC | APPROVED | DIN 02492350 |
Who else supplies ERYTHROMYCIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ERYTHROMYCIN appears in 767 registered pack listings across 11 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.